Julian Jones – VJRegenMed

Utilizing bioglass as a drug delivery system

Simon Ng — Mon, 17 Jan 2022 13:05:30 +0000

Julian Jones, PhD, Imperial College London, London, UK, describes the applications of bioglass in osteoporosis and cancer. Nanoparticles including bioglass release ions and can be directed to specific tissue, making them a suitable drug delivery system. Bioglass containing strontium ranelate have shown to safely mitigate the effects of osteoporosis by maintaining osteoblast activity, and when containing zinc, can effectively kill cancer cells without harming healthy tissue. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

Enhanced bioglass for cartilage regeneration

Simon Ng — Tue, 11 Jan 2022 17:26:15 +0000

Julian Jones, PhD, Imperial College London, London, UK, discusses the development of bouncy bioglass for articular cartilage repair. Current cartilage regeneration involving microfracture surgery only produces scar-like cartilage and 3D-printed bouncy bioglass of a certain pore channel size enables production of articular cartilage. Whilst initial in vivo studies have demonstrated favorable cartilage growth in animal models, further research is required to elucidate the exact composition of type I and type II collagen in the cartilage. This interview took place at 6th world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

What to expect in the field of orthobiologics

Simon Ng — Tue, 11 Jan 2022 17:26:13 +0000

Julian Jones, PhD, Imperial College London, London, UK, provides an overview of advancements in bone and cartilage regeneration. Hydrogel scaffolds have demonstrated to aid promising cartilage regeneration, with its high water content mimicking the extracellular matrix. Within the field of bone regeneration, the development of load-bearing materials and scaffolds remain an unmet need and Prof. Jones additionally highlights progress within skin regeneration, which can now potentially treat severe injuries. This interview took place at 6th world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).